© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
April 19, 2021
Ennis James, MD, discusses the challenges and lingering questions associated with sarcoidosis
April 15, 2021
Elevated B cell activating factor levels in children and adults were associated with the development of FVIII inhibitors, which may lead to FVIII infusion failures.
April 14, 2021
SDOCT imaging shows that sickle cell patients with no clinical evidence of retinopathy have considerably lower central macular thickness when compared with healthy controls.
April 11, 2021
Compared with controls, children and adolescents with sickle cell anemia were more likely to be underweight and exhibit signs of stunting and wasting.
April 09, 2021
Patients who received voxelotor 1500 mg achieved significant improvements in markers of hemolysis through week 72 when compared with the placebo group.
April 06, 2021
A new study supports the potential association between hydroxyurea and improved neurocognitive performance in pediatric patients.
April 02, 2021
The PCSK9 inhibitor was linked to 27% mean reduction in LDL-C over 12 weeks.
April 01, 2021
New phase 2 data from a 24-week assessment suggest the first-in-class drug could benefit exercise and pulmonary-vascular outcomes.
March 30, 2021
The new indication for the liposomal-combination therapy is based on safety outcomes from a pair of single-arm trials.
A budget impact analysis suggest the burgeoning drug class may not be as available as it could be for sickle cell patients.